MedPath

An Analysis of the Efficacy of High Dose Isofosfamide Through Elastomer

Completed
Conditions
Osteosarcoma Recurrent
Registration Number
NCT04651569
Lead Sponsor
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Brief Summary

A multicentre, observational, retrospective study to analyse the efficacy of high dose isofosfamide thorugh elastomer in patients with relapsed/ refractory osteosarcoma

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • Diagnosis of high risk relapsed/ refractory osteosarcoma
  • Aged <= 40 years at the beginning of treatment
  • at least one completed cycle of HD IFO through elastomer (14g/mq) in 14 days
  • disease evaluation according to RECIST criteria v.1.1
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
toxicity according to CTCAE v.5.0Evaluation to be recorded at each disease assessment through imaging (PET/CT/MRI)

Disease evaluation

Progression Free SurvivalEvaluated during the first 4 months at the end of treatment

Disease remission or disease progression

growth modulation index - GMIEvaluation to be recorded at each disease assessment through imaging (PET/CT/MRI)

ratio of time to progression (TTP) with nth line of therapy (TTPn) to the most recent prior line of therapy (TTPn-1)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Istituto Ortopedico Rizzoli

🇮🇹

Bologna, Italy

Azienda Ospedaliero Universitaria Meyer

🇮🇹

Florence, Italy

IRCCS Istituto Nazionale dei Tumori - S.C. Pediatria

🇮🇹

Milan, Italy

Regina Elena National Cancer Institute IRCCS

🇮🇹

Roma, Italy

OIRM - AOU Città della Salute e della Scienza di Torino

🇮🇹

Torino, Italy

Istituto Ortopedico Rizzoli
🇮🇹Bologna, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.